Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Coenzyme Q10 to slow down the effects of Parkinson's disease?

Rush University Medical Center is participating in a large-scale, multi-center clinical trial in the U.S. and Canada to determine whether a vitamin-like substance, in high doses, can slow the progression of Parkinson's disease, a neurodegenerative disorder that affects about one million people in the United States.

22 Sep 2009

Phase II trial of Impax Pharmaceuticals' Parkinson’s disease drug candidate successful

Impax Pharmaceuticals, the brand products division of Impax Laboratories, Inc. (NASDAQ: IPXL) today reported the positive results from a recently completed Phase II trial of its late-stage Parkinson’s Disease drug candidate IPX066

21 Sep 2009

Study reveals that KCNE2 and KCNQ1 mutations can results in thyroid dysfunction

Genes previously known to be essential to the coordinated, rhythmic electrical activity of cardiac muscle -- a healthy heartbeat -- have now also been found to play a key role in thyroid hormone (TH) biosynthesis, according to Weill Cornell Medical College researchers.

21 Sep 2009

"Our request for information gets denied by Governor's office": AWF Executive Director Brian Johnson

Last week, the Alliance for Worker Freedom (AWF) called on Kansas Gov. Mark Parkinson (D) to release financial documents and correspondence surrounding his Departments using taxpayer money and state resources to collect healthcare provider names and addresses for the Service Employee International Union (SEIU).

18 Sep 2009

Scientific discoveries must be translated into practical applications to improve patients' health

Experts gathered on Capitol Hill today to address the impact of policies related to translational research and U.S. medical innovation. The briefing, titled Translational Research: From Bench to Bedside, was sponsored by the Council for American Medical Innovation as the second in a three-part series, Recovery Through Discovery, which examines medical innovation as a driver of U.S. economic recovery and enhanced global leadership in science.

18 Sep 2009

Protein aggregation is linked to many conformational diseases

Researchers at the Department of Biochemistry and Molecular Biology of Universitat Autònoma de Barcelona (UAB) have revealed the process by which proteins with a tendency to cause conformational diseases such as amyotrophic lateral sclerosis, familial amyloidotic polyneuropathy, familial amyloidotic cardiomyopathy, etc. finally end up causing them.

17 Sep 2009

Findings may lead to drugs that destroy TB in dormant stage of lifecycle

Attempts to eradicate tuberculosis (TB) are stymied by the fact that the disease-causing bacteria have a sophisticated mechanism for surviving dormant in infected cells. Now, a team of scientists led by researchers from Weill Cornell Medical College has identified compounds that inhibit that mechanism -- without damaging human cells.

17 Sep 2009

Legislation grants improve research and employment initiatives in Indiana University medical campus

Indiana University School of Medicine scientists have received more than $12 million in grants funded by the federal economic stimulus legislation, funding that has bolstered both research initiatives and research employment on the medical center campus.

16 Sep 2009

Findings could lead to new neurological treatments

The power of the imagination is well-known: it's no surprise that scary music is scarier with your eyes closed. But now neuroscientist and psychiatrist Prof. Talma Hendler of Tel Aviv University's Functional Brain Center says that this phenomenon may open the door to a new way of treating people with Alzheimer's, Parkinson's and other neurological diseases.

16 Sep 2009

Council briefing series to examine role of public policy in promoting medical innovation

The Council for American Medical Innovation will host a breakfast briefing on Capitol Hill titled "Translational Research - From Bench to Bedside." Health policy experts will explore important changes needed to improve the process of development and approval for safe and effective drugs, biologics, medical devices and diagnostics.

15 Sep 2009

Service Employees International Union illegally collect Kansas healthcare workers' information

The Alliance for Worker Freedom (AWF) calls on Kansas Governor Mark Parkinson (D) to make information available regarding his Department's use of state resources and taxpayer money to obtain personal contact information of healthcare providers on behalf of the Service Employees International Union / SEIU Kansas.

15 Sep 2009

iMedicor and Transgenomic to develop an educational marketing program for NuroPro

iMedicor and Transgenomic today announced that they have signed an agreement to develop an educational marketing program for NuroPro, Transgenomic’s diagnostic tests for Alzheimer’s and Parkinson’s disease.

15 Sep 2009

Neurologix to showcase novel gene transfer approach to Parkinson’s disease

Neurologix, Inc. (OTCBB: NRGX), a biotechnology company engaged in the development of innovative gene therapies for the brain and central nervous system, announced today that the company will showcase its novel gene transfer approach to Parkinson’s disease.

15 Sep 2009

Pesticide exposure is linked to Parkinson's disease

Individuals whose occupation involves contact with pesticides appear to have an increased risk of having Parkinson's disease, according to a report in the September issue of Archives of Neurology, one of the JAMA/Archives journals.

15 Sep 2009

Vivakor completes third-party validation testing of its VivaBlend nutraceutical product

Vivakor™, Inc. (OTCBB: VIVK) today announced the results of independent, third-party validation testing of its VivaBlend™ nutraceutical product. VivaBlend is a powerful extract developed by the scientists at Vivakor and is derived from over 18 highly bioactive fruits, vegetables and legumes. Through a proprietary formulation and extraction process, Vivakor scientists have maximized the health benefits of VivaBlend by creating an optimum blend of super-antioxidants and powerful plant phenolics and flavonoids.

14 Sep 2009

APDA/NPF Parkinson's conference educates the young onset PD community

The American Parkinson Disease Association (APDA) National Young Onset Center and the National Parkinson Foundation (NPF) Young Onset Parkinson Network are co-sponsoring a series of conferences for those living with young-onset Parkinson's disease and their caregivers. The first conference will be held in Dallas, Texas on October 23-24.

14 Sep 2009

Parkinson Society Canada's SuperWalk raises record amount

SuperWalk for Parkinson's raised a record $2.46 million this year. Lauren Collins, star of Degrassi: The Next Generation, unveiled the new look SuperWalk for 2010 at this year's Toronto walk. Collins, left, walked with her mother, Sari, for her father who has had Parkinson's for over 20 years.

14 Sep 2009

Scientific program to treat and prevent mental disorders

Mental disorders are a global problem and represent one of the biggest challenges for health care systems. In the world, there are some 500 million people suffering from mental disorders, and in the European Union, mental disorders range as one of the leading causes of disease burden.

14 Sep 2009

FDA accepts Merz Pharmaceuticals' premarket approval application for Belotero Balance

Merz Pharmaceuticals, LLC, a leading specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review Merz's premarket approval (PMA) application for Belotero(R) Balance.

11 Sep 2009

CytRx granted patent for molecular chaperone amplifier drug candidate

CytRx Corporation, a biopharmaceutical research and development company engaged in the development of high-value human therapeutics, today announced that it has been granted a key patent by the European Patent Office that covers through 2024 the use of its orally available molecular chaperone amplifier drug candidate arimoclomol for the treatment or prevention of neurodegenerative diseases of the central nervous system (CNS).

10 Sep 2009

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Coenzyme Q10 to slow down the effects of Parkinson's disease?

Phase II trial of Impax Pharmaceuticals' Parkinson’s disease drug candidate successful

Study reveals that KCNE2 and KCNQ1 mutations can results in thyroid dysfunction

"Our request for information gets denied by Governor's office": AWF Executive Director Brian Johnson

Scientific discoveries must be translated into practical applications to improve patients' health

Protein aggregation is linked to many conformational diseases

Findings may lead to drugs that destroy TB in dormant stage of lifecycle

Legislation grants improve research and employment initiatives in Indiana University medical campus

Findings could lead to new neurological treatments

Council briefing series to examine role of public policy in promoting medical innovation

Service Employees International Union illegally collect Kansas healthcare workers' information

iMedicor and Transgenomic to develop an educational marketing program for NuroPro

Neurologix to showcase novel gene transfer approach to Parkinson’s disease

Pesticide exposure is linked to Parkinson's disease

Vivakor completes third-party validation testing of its VivaBlend nutraceutical product

APDA/NPF Parkinson's conference educates the young onset PD community

Parkinson Society Canada's SuperWalk raises record amount

Scientific program to treat and prevent mental disorders

FDA accepts Merz Pharmaceuticals' premarket approval application for Belotero Balance

CytRx granted patent for molecular chaperone amplifier drug candidate

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in